Login / Signup

Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats.

Lishi ShaoQixiang FangChen ShiYa ZhangChunjuan XiaYifan ZhangJiaping WangFukun Chen
Published in: Journal of receptor and signal transduction research (2023)
BMMSCs alleviate CKD, possibly resulting from the inhibition of kidney ferroptosis by regulating the Nrf2-Keap1/p53 pathway.
Keyphrases
  • chronic kidney disease
  • cell death
  • end stage renal disease
  • oxidative stress
  • protein protein
  • small molecule